CHI3L1 and myeloid sarcoma: Elevated CSF levels of chitinase-3-like-1 (CHI3L1) have been linked to cognitive impairments in early MS, and the progression to clinically definite MS, as well as disease progression in general; CHI3L1 has been shown to activate microglia and macrophages, thereby indirectly promoting demyelination (47).